Surcoreana de regenerative medicine receives permission to sell product based on human tissue in Peru
The South Korean company L&C Bio received the approval of the Directorate General for Drugs, Insumos and Drug Addiction (Digegedid) to market in Peru Re2O, a product based on extracellular matrix (ECM) human skin fabric.The authorisation was granted by...
IntelMap indexes open-source reporting. This page identifies what a source reported; it does not independently confirm the claim.
2 reports · 2 sources
GestiónSurcoreana de regenerative medicine receives permission to sell product based on human tissue in PeruGestiónSurcoreana de regenerative medicine receives permission to sell product based on human tissue in Peru10 recorded states
Signal first indexedP1 · 68% quality · 1 source
Corroboration 1→2 sources · quality 68→72P1 · 72% quality · 2 sources
Quality 72→76P1 · 76% quality · 2 sources
Quality 76→80P1 · 80% quality · 2 sources
Quality 80→84P1 · 84% quality · 2 sources
Quality 84→88P1 · 88% quality · 2 sources
Quality 88→92P1 · 92% quality · 2 sources
Quality 92→96P1 · 96% quality · 2 sources
Quality 96→99P1 · 99% quality · 2 sources
Corroboration 2→1 sourcesP1 · 99% quality · 1 source